GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (CHIX:GRFe) » Definitions » EV-to-Revenue

Grifols (CHIX:GRFE) EV-to-Revenue : 2.63 (As of Dec. 14, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Grifols EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Grifols's enterprise value is €14,173 Mil. Grifols's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €5,380 Mil. Therefore, Grifols's EV-to-Revenue for today is 2.63.

The historical rank and industry rank for Grifols's EV-to-Revenue or its related term are showing as below:

CHIX:GRFe' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.1   Med: 4.34   Max: 5.95
Current: 2.63

During the past 13 years, the highest EV-to-Revenue of Grifols was 5.95. The lowest was 1.10. And the median was 4.34.

CHIX:GRFe's EV-to-Revenue is ranked worse than
52.01% of 994 companies
in the Drug Manufacturers industry
Industry Median: 2.495 vs CHIX:GRFe: 2.63

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-14), Grifols's stock price is €8.794. Grifols's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €7.69. Therefore, Grifols's PS Ratio for today is 1.14.


Grifols EV-to-Revenue Historical Data

The historical data trend for Grifols's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols EV-to-Revenue Chart

Grifols Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.52 4.55 4.03 3.10 3.35

Grifols Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.21 4.28 3.35 3.17 1.63

Competitive Comparison of Grifols's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Grifols's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grifols's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Grifols's EV-to-Revenue falls into.



Grifols EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Grifols's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=14173.205/5380.413
=2.63

Grifols's current Enterprise Value is €14,173 Mil.
Grifols's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €5,380 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grifols  (CHIX:GRFe) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Grifols's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=8.794/7.694
=1.14

Grifols's share price for today is €8.794.
Grifols's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €7.69.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grifols EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Grifols's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Grifols Business Description

Address
Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

Grifols Headlines

No Headlines